Amoxicillin appears to be ineffective for cough
Taken from The Lancet – by Bruce Sylvester – Patients with cough treated with amoxicillin do not recover significantly more quickly or have significantly fewer symptoms than other… read more.
Taken from The Lancet – by Bruce Sylvester – Patients with cough treated with amoxicillin do not recover significantly more quickly or have significantly fewer symptoms than other… read more.
Egg allergic children did not have adverse reactions to single dose of influenza vaccine in multi-center study
Social adversity and ethnicity linked to significantly poorer test scores in Key Stages 1-3.
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.
An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3… read more.
Data demonstrate superior patient outcomes with B-R in first-line treatment of iNHL and MCL, compared with current standard of care.
by Bruce Sylvester – FDA Highlights – According to a study published online on September 7, 2012 in the American Journal of Respiratory and Critical Care Medicine, treatment… read more.
by Gary Finnegan – World Health Matters (Canada) – Austerity measures introduced by European governments and the deepening threat of insolvency faced by the US Medicare system have… read more.
by Marybeth Burke – Regorafenib significantly improved progression-free survival (PFS) and disease control rate (DCR) in patients with advanced gastrointestinal stromal tumours (GIST) that progress due to resistance… read more.
by Marybeth Burke – The investigational agent trastuzumab emtansine (T-DM1) demonstrated improved efficacy over capecitibine plus lapatinib and improved progression-free survival (PFS) in women with HER2-positive locally advanced… read more.
by Marybeth Burke – Continuous hormonal therapy is more effective than intermittent hormonal therapy for men with hormone-sensitive metastatic prostate cancer with minimal disease spread,
25 Feb 2012 – EAU Paris – Men often finds it difficult to talk with primary health specialists and this is certainly true in the case of BPH.